Zobrazeno 1 - 10
of 175
pro vyhledávání: '"Gulden Menderes"'
Publikováno v:
Gynecologic Oncology Reports, Vol 44, Iss , Pp 101102- (2022)
Background: Extraskeletal osteosarcoma is an extremely rare malignant neoplasm. Literature regarding primary osteosarcoma of the uterus is confined to only a small number of case reports.Case: A 57-year-old female with a history of uterine fibroids p
Externí odkaz:
https://doaj.org/article/1dcd378af34e4405929569f1763e0c7a
Publikováno v:
Gynecologic Oncology Reports, Vol 40, Iss , Pp 100959- (2022)
Externí odkaz:
https://doaj.org/article/3acc71e9fcb84426b76dbc16d66c4e8a
Autor:
Jessie Y. Li, Levent Mutlu, Joan Tymon-Rosario, Wafa Khadraoui, Nupur Nagarkatti, Pei Hui, Natalia Buza, Lingeng Lu, Peter Schwartz, Gulden Menderes
Publikováno v:
Gynecologic Oncology Reports, Vol 39, Iss , Pp 100913- (2022)
Objective: To examine clinicopathologic characteristics and oncologic outcomes of patients diagnosed with Mullerian adenosarcoma and to evaluate ovarian preservation as a practical management option in early-stage disease. Methods: A retrospective re
Externí odkaz:
https://doaj.org/article/493efdc23a7f4653ad2ee708eb39fcde
Autor:
Emanuele Perrone, Paola Manara, Salvatore Lopez, Stefania Bellone, Elena Bonazzoli, Aranzazu Manzano, Luca Zammataro, Anna Bianchi, Burak Zeybek, Natalia Buza, Joan Tymon‐Rosario, Gary Altwerger, Chanhee Han, Gulden Menderes, Gloria S. Huang, Elena Ratner, Dan‐Arin Silasi, Masoud Azodi, Pei Hui, Peter E. Schwartz, Giovanni Scambia, Alessandro D. Santin
Publikováno v:
Molecular Oncology, Vol 14, Iss 3, Pp 645-656 (2020)
Endometrial cancer is the most common gynecologic malignancy in developed countries. The antibody–drug conjugate (ADC) sacituzumab govitecan (SG) targets trophoblast cell‐surface antigen‐2 (Trop‐2) – a cell‐surface glycoprotein highly exp
Externí odkaz:
https://doaj.org/article/4855a08bc9b94673965f1e87191a9728
Autor:
Emily M. Webster, Ghanshyam S. Yadav, Stefan Gysler, Blair McNamara, Jonathan Black, Joan Tymon-Rosario, Burak Zeybek, Chanhee Han, Christopher K. Arkfeld, Vaagn Andikyan, Gulden Menderes, Gloria Huang, Masoud Azodi, Dan-Arin Silasi, Alessandro D. Santin, Peter E. Schwartz, Elena S. Ratner, Gary Altwerger
Publikováno v:
Gynecologic Oncology Reports, Vol 34, Iss , Pp 100667- (2020)
Research within a gynecologic oncology population has lagged behind the uptake in use of medical cannabis for symptom control. This study seeks to evaluate patient experience with prescribed medical cannabis obtained through licensed dispensaries in
Externí odkaz:
https://doaj.org/article/efa0abb420a54db1b2dd8238713b1aa0
Publikováno v:
Gynecologic Oncology Reports, Vol 34, Iss , Pp 100673- (2020)
Externí odkaz:
https://doaj.org/article/a84e8b3a757c428db521c0e11f5d1a20
Autor:
Emanuele Perrone, Salvatore Lopez, Burak Zeybek, Stefania Bellone, Elena Bonazzoli, Silvia Pelligra, Luca Zammataro, Aranzazu Manzano, Paola Manara, Anna Bianchi, Natalia Buza, Joan Tymon-Rosario, Gary Altwerger, Chanhee Han, Gulden Menderes, Elena Ratner, Dan-Arin Silasi, Masoud Azodi, Pei Hui, Peter E. Schwartz, Giovanni Scambia, Alessandro D. Santin
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Background: Epithelial ovarian cancer (EOC) is the most lethal gynecologic malignancy. Sacituzumab govitecan (SG) is a novel antibody-drug-conjugate (ADC) targeting trophoblast-antigen-2 (Trop-2), a cell surface glycoprotein highly expressed in many
Externí odkaz:
https://doaj.org/article/2f3ecf6859594b69a06c011b962dbb6a
Autor:
Benjamin B. Albright, Jonathan D. Black, Rachel Passarelli, Stefan Gysler, Margaret Whicker, Gary Altwerger, Gulden Menderes, Natalia Buza, Pei Hui, Alessandro D. Santin, Masoud Azodi, Dan-Arin Silasi, Elena S. Ratner, Babak Litkouhi, Peter E. Schwartz
Publikováno v:
Gynecologic Oncology Reports, Vol 23, Iss C, Pp 28-33 (2018)
Objective: This study sought to evaluate characteristics of cases of free-floating tumor fragments within the lumen of fallopian tubes (‘floaters’) on final pathology for Type I and Type II endometrial adenocarcinoma, including relationships with
Externí odkaz:
https://doaj.org/article/e302ba2713a344eab5ae5966c15b15a2
Autor:
Ghanshyam Yadav, Dana M. Roque, Stefania Bellone, Diego D. Manavella, Tobias M.P. Hartwich, Margherita Zipponi, Justin Harold, Joan Tymon-Rosario, Levent Mutlu, Gary Altwerger, Gulden Menderes, Elena Ratner, Natalia Buza, Pei Hui, Gloria S. Huang, Vaagn Andikyan, Mitchell Clark, Masoud Azodi, Peter E. Schwartz, Ludmil B. Alexandrov, Alessandro D. Santin
Publikováno v:
Gynecologic Oncology. 166:351-357
Uterine serous carcinoma (USC) is an aggressive variant of endometrial cancer with a poor prognosis. Approximately 30% of USC overexpress HER2/neu, a recognized target for trastuzumab in advanced/recurrent HER2/neu-positive USC. We evaluated the effi
Autor:
Joan R. Tymon-Rosario, Paola Manara, Diego D. Manavella, Stefania Bellone, Tobias Max Philipp Hartwich, Justin Harold, Yang Yang-Hartwich, Margherita Zipponi, Jungmin Choi, Kyungjo Jeong, Levent Mutlu, Kevin Yang, Gary Altwerger, Gulden Menderes, Elena Ratner, Gloria S. Huang, Mitchell Clark, Vaagn Andikyan, Masoud Azodi, Peter E. Schwartz, Ludmil B. Alexandrov, Alessandro D. Santin
Publikováno v:
Gynecologic Oncology. 166:117-125
Carcinosarcoma (CS) of the ovary and uterus are highly aggressive malignancies associated with poor survival. Poly(ADP-ribose)-polymerase inhibitors (PARPi) are targeted agents impairing DNA repair via homologous-recombination-deficiency (HRD) mechan